Atrial fibrillation and Nail bed inflammation


Nail bed inflammation is found among people with Atrial fibrillation, especially for people who are male, 60+ old.

The study analyzes which people have Nail bed inflammation with Atrial fibrillation. It is created by eHealthMe based on reports of 16 people who have Atrial fibrillation from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 06, 2023

16 people who have Atrial Fibrillation and Nail Bed Inflammation are studied.

What is Atrial fibrillation?

Atrial fibrillation (fibrillation of the muscles of the atria of the heart) is found to be associated with 3,646 drugs and 3,475 conditions by eHealthMe.

What is Nail bed inflammation?

Nail bed inflammation (infection of nail bed) is found to be associated with 274 drugs and 238 conditions by eHealthMe.

Number of Nail bed inflammation in Atrial fibrillation reports submitted per year:

Would you have Nail bed inflammation when you have Atrial fibrillation?

Gender of people who have Atrial Fibrillation and experienced Nail Bed Inflammation *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Atrial Fibrillation and experienced Nail Bed Inflammation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common co-existing conditions for these people *:

  1. Nausea (feeling of having an urge to vomit): 16 people, 100.00%
  2. Infection: 16 people, 100.00%
  3. High Blood Pressure: 16 people, 100.00%
  4. Colon Cancer: 16 people, 100.00%
  5. Cholinergic Syndrome (symptoms of increased cholinergic stimulation): 16 people, 100.00%
  6. Cardiac Failure: 16 people, 100.00%
  7. Weight Decreased: 15 people, 93.75%
  8. Oedema Peripheral (superficial swelling): 14 people, 87.50%
  9. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 13 people, 81.25%
  10. Constipation: 10 people, 62.50%

Common drugs taken by these people *:

  1. Voltaren: 15 people, 93.75%
  2. Vitamin B6: 14 people, 87.50%
  3. Hctz: 14 people, 87.50%
  4. Vitamin B1: 10 people, 62.50%
  5. Xeloda: 5 people, 31.25%
  6. Novalgin: 3 people, 18.75%
  7. Pyridoxine: 2 people, 12.50%
  8. Pantoprazole: 2 people, 12.50%
  9. Morphine: 2 people, 12.50%

Common symptoms for these people *:

  1. Weight Decreased: 16 people, 100.00%
  2. Visual Impairment: 16 people, 100.00%
  3. Blood Bilirubin Increased: 16 people, 100.00%
  4. Blood Uric Acid Increased: 16 people, 100.00%
  5. Breathing Difficulty: 16 people, 100.00%
  6. Constipation: 16 people, 100.00%
  7. Dry Mouth: 16 people, 100.00%
  8. Fatigue (feeling of tiredness): 16 people, 100.00%
  9. Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 16 people, 100.00%
  10. Gamma-Glutamyltransferase Increased: 16 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Nail bed inflammation?

Check whether Nail bed inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Nail bed inflammation:

All the drugs that are associated with Nail bed inflammation:

All the conditions that are associated with Nail bed inflammation:

How the study uses the data?

The study is based on Nail bed inflammation and Atrial fibrillation, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: